1.
- Neoplasma : journal of experimental and clinical oncology / Cancer Research Institute of the Slovak Academy of Sciences. 2012. Vol. 59, no. 1 - s. 1-120 [2, currently available 0, at library only 2]
- References
- PERIODIKÁ-Súborný záznam periodika (0.0-)
- ARTICLES
- 2012:
- Breast cancer patients with hypermethylation in the promoter of BRCA1 gene exhibit favorable clinical status (0.0-),
- Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma (0.0-),
- Differentiation pathways in carcinogenesis and in chemo-and radioresistance (0.0-),
- Epidermal growth factor receptor mutations in small cell lung cancer patients who received surgical resection in China (0.0-),
- Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experience (0.0-),
- Gentiana asclepiadea and Armoracia rusticana can modulate the adaptive response induced by zeocin in human lymphocytes (0.0-),
- Gpnmb/osteoactivin, an attractive target in cancer immunotherapy (0.0-),
- Characterization of adrenal metastatic cancer using FDG PET/CT (0.0-),
- Long-term trends in the development of the epidemiology of breast cancer in the Slovak and Czech Republic with reference to applied screening and international comparisons (0.0-),
- Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population (0.0-),
- Over-expressing CYLD augments antitumor activity of TRAIL by inhibiting the NF-κB survival signaling in lung cancer cells (0.0-),
- Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo (0.0-),
- Stereotactic radiotherapy as a sole or salvage therapy in non-small cell lung cancer patients (0.0-),
- The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma (0.0-),
- The influence of neuropilin-1 silencing on semaphorin 3A and 3C activity in B16 murine melanoma cells (0.0-)